inpremzia
baxter holding b.v. - insulin human (rdna) - Šećerna bolest - lijekovi koji se koriste u dijabetesu - inpremzia is indicated for the treatment of diabetes mellitus.
thalidomide lipomed
lipomed gmbh - Талидомид - multipli mijelom - imunosupresivi - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.
euvax b 20mcg/ml suspenzija za injekciju
dio stranog druŠtva "sanofi - aventis" - podgorica - vakcina protiv hepatitisa b, rekombinantna - suspenzija za injekciju - 20mcg/ml
euvax b 20mcg/ml suspenzija za injekciju
dio stranog druŠtva "sanofi - aventis" - podgorica - vakcina protiv hepatitisa b, rekombinantna - suspenzija za injekciju - 20mcg/ml
euvax b 10mcg/0.5ml suspenzija za injekciju
dio stranog druŠtva "sanofi - aventis" - podgorica - vakcina protiv hepatitisa b, rekombinantna - suspenzija za injekciju - 10mcg/0.5ml
euvax b 20mcg/ml suspenzija za injekciju
dio stranog druŠtva "sanofi - aventis" - podgorica - vakcina protiv hepatitisa b, rekombinantna - suspenzija za injekciju - 20mcg/ml
euvax b 10mcg/0.5ml suspenzija za injekciju
dio stranog druŠtva "sanofi - aventis" - podgorica - vakcina protiv hepatitisa b, rekombinantna - suspenzija za injekciju - 10mcg/0.5ml
euvax b 10mcg/0.5ml suspenzija za injekciju
dio stranog druŠtva "sanofi - aventis" - podgorica - vakcina protiv hepatitisa b, rekombinantna - suspenzija za injekciju - 10mcg/0.5ml
scudotex, rekordsan, scudovaris, tecnoped i daga
rozi step d.o.o. - ortopedska pomagala
invokana
janssen-cilag international nv - canagliflozin - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - invokana is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise:as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5.